• Deep knowledge of peptide structure-activity relationships and novel amino acid chemistry • Broad understanding of organic and biological chemistry including nucleic acid and saccharide synthesis• Key driver of late-stage discovery and API process development of the approved macrocyclic peptide drug zilucoplan/Zilbrysq (RA101495) from phase 1 through establishment of phase 3 and commercial processes.• Clear and effective oral and written communicator and a builder of high-performance teams.• Outsourcing expert with a history of successful CDMO/CRO collaboration and supply chain assurance.• A natural leader, mentor, and motivator who thrives in environments requiring collaborative problem solving while managing direct reports and company partners in cross-disciplinary scientific teams. • Innovation focus with consistent patenting and high-impact publications. Fellow, National Academy of Inventors